<DOC>
	<DOCNO>NCT01104012</DOCNO>
	<brief_summary>The purpose study verify validate intrinsic diagnostic value term sensitivity specificity proteomic profile determine pre-study discriminating allergy relate asthma allergy relate rhinitis .</brief_summary>
	<brief_title>Validation Proteomic Analyses Allergic Asthma Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<criteria>sign consent neversmokers nonsmoking least 2 year + &lt; 5 pack per year capable understanding study patient affiliate social security system positive skin test ( least one Montpellier region pneumoallergens ) treat nasal inhaled corticoid , leucotriene receptor antagonist , antiIgE , Theophylline , antihistamine , sodium cromoglycate , betablockers , benzodiaz√©pine , oral corticoid : treatment must interrupt least 72 hour Comorbidities : none ; comorbidities accept dental infection ( ) 3 month precede study suspect alcoholism drug abuse chronic viral infection ( hepatitis , HIV ) patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>